When Mary Dunnigan arrived in Baton Rouge in 1998, she came with more than a suitcase—she brought a dream to create something ...

FDA approval of EKTERLY makes KalVista Pharmaceuticals, Inc. the first to offer an oral on-demand HAE therapy. Click here to find out why KALV is a Strong Buy.

Kesha may now be a free and independent artist, but up until just a couple of years ago, she was contractually obligated to work with the same person she was suing on allegations of sexual assault.

Submission is based on long-term Phase 3 data demonstrating 63 percent reduction in risk of relapse in adults with schizophrenia compared to placebo CAPLYTA® is FDA ...

Neoadjuvant and adjuvant pembrolizumab added to standard care significantly improves event-free survival in HNSCC.

Jasper Therapeutics’ stock has dropped by more than 50% after the company announced it was looking into the impact of a ...

Surprised to hear us recommend pants your pops swears by? You shouldn’t be. In fact, their righteous, anti-fashion dadliness ...

Tividenofusp alfa is a novel central nervous system-penetrant enzyme replacement therapy designed to address the neurological manifestations of MPS II by delivering IDS into the brain and body.

The FDA has approved Benlysta for SC administration using an autoinjector in patients 5 years of age and older with active LN.

The FDA has approved Gamifant for the treatment of adult and pediatric patients with HLH/MAS in known or suspected Still disease.

Luspatercept-aamt shows significant survival benefits and transfusion independence in lower-risk MDS, reshaping treatment ...